Michell G. Email & Phone Number

Texas, United States

United States

Dallas, Texas, United States

Promoted to lead and execute upon all operational aspects of the marketing process in support of the US Commercial organization's promotional activities across 4 brands, optimizing the group's effectiveness to support commercial efforts in the US. Responsibilities included oversight of medical, regulatory, legal review of processes, execution of Speaker.

Western Half Of US (including AK & HI)

Recruited, hired and led a team of 6 Senior Oncology Account Managers and 1 Remote Sales Specialist to launch the first ADC, tivdak, in metastatic and recurrent cervical cancer (product was co-promoted with Genmab.). Ensured team had the right resources to successfully execute on identified business opportunities. Division finished #1, with Circle of.

AZ, NM, TX, LA, MS, AL, AR, TN, FL Panhandle

Built and led a team of 7 Territory Business Managers, 1 Clinical Nurse Educator and 1 Field Reimbursement Manager to launch a novel technology, JELMYTO, for instillation at Ambulatory Surgical Centers/Hospitals as first non-surgical treatment for patients with low grade upper tract urothelial cancer to UroOncologists and Medical Oncologists at leading.

TX, OK, NM

One of first 175 employees hired to build and lead a team of 8 Territory Managers, responsible for commercialization of an FDA Designated Breakthrough Therapy. Product: Rucaparib (PARP Inhibitor – Medicare Part D.) Tumor line – Advanced Ovarian. - 2019 - Number 1 in the nation YTD thru August - 2018 Finished the year 115% to goal, #2 in country. APEX Award.

TX, NM, AZ, WY, ID, UT

• Led a team of 7 Hematology Oncology Consultants. Tumor lines: mBC, mNSCLC, mPAC. Product: Abraxane® (Medicare Part B).
• 101.7% to goal attainment Q1’2015 (12,774 vials), finishing ahead of the region (95.94% to goal) and the nation (97.30% to goal)
• Developed and led a 1-day Texas Oncology Task Force Strategy Planning Meeting resulting in strategic alignment, collaboration and accountability across multiple internal stakeholders

TX/NM

-Led a team of 8 Oncology Account Specialists, covering Community Oncology Clinics across Texas and New Mexico. -Led team through successful launch of FDA Breakthrough Designation melanoma product, Tafinlar/Mekinist, in the oral marketplace. Additional solid tumor and hematology products included: Promacta, Votrient and Arzerra.-Oncology business unit was.

Washington D.C., MD, VA, W. VA, PA

• Promoted to lead a team of 6 HSM’s (Hospital System Managers), who combined managed 21 Academic, DoD and VA Accounts, including UPMC, Georgetown, Johns Hopkins, Walter Reed National Military Medical Center and.
• Held team accountable to execution of regional/district strategies, contract pull through and delivering consistent sales results and unit growth of all brands semester over semester.

LA, MS, AL, GA, FL, PR, TN, MO

• Promoted to manage key hospital accounts - South East Region. Reported to Executive Director of Regional Sales and worked alongside District Sales Managers to identify growth opportunities, strategically win new.
• #1 Region in the Nation 2008
• Multiple formulary wins over 1½ year period in a highly competitive market.
• Established and strengthened business relationships with administrators, GPO’s, pharmacy directors and clinical oncology and nephrology pharmacists
• Collaborated with Clinical Specialist team, Brand Teams, Nephrology Business Unit and Health System Manager Team to discuss market dynamics, account planning, strategy and pull through, GPO corporate direction.

Ba, English

Adn, Registered Nursing/Registered Nurse